???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Amparo Sanchez Navarro

Nomes de citação

  • Navarro, Amparo

Identificadores de autor

Ciência ID
A517-CEC6-A800
ORCID iD
0000-0002-4291-1035

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
1975/10/01 - 1980/07/01
Concluído
 Pharmacy (Laurea Magistrale)
Universidad de Salamanca, Espanha
"Experimental pharmacokinetics of Dibekacin, a new aminoglycoside antibiotic" (TESE/DISSERTAÇÃO)
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2011 - Atual Professor Catedrático (Docente Universitário) Universidad de Salamanca, Espanha
Instituto Politécnico da Guarda Escola Superior de Saúde, Portugal
Projetos

Bolsa

Designação Financiadores
2019/01 - Atual Liposomes as pulmonary carriers for passive drug targeting. Application to sildenafil citrate
KAP3
Investigador responsável
Universidad de Salamanca Facultad de Farmacia, Espanha
 Fundacion de la Universidad de Salamanca
Em curso
2008/06 - 2015/06 Development, characterization and evaluationof liposomes, ethosomes and transfersomes by using an isolated rat lung as experimental model
SAO11A08
Investigador responsável
Universidad de Salamanca Facultad de Farmacia, Espanha
 Junta de Castilla y León Consejería de Educación
Concluído
2013/01 - 2014/01 PB/PK modeling as useful tool for translacional medicine in the field of pharmacological therapy
JBP3
Investigador responsável
Universidad de Salamanca, Espanha
 Junta de Castilla y Leon Consejeria de Sanidad
Concluído
Produções

Publicações

Artigo em revista
  1. Andreia Alves; Sónia P. Miguel; André R.T.S. Araujo; María José de Jesús Valle; Amparo Sánchez Navarro; Ilídio J. Correia; Maximiano P. Ribeiro; Paula Coutinho. "Xanthan Gum–Konjac Glucomannan Blend Hydrogel for Wound Healing". Polymers 12 1 (2020): 99-99. https://doi.org/10.3390/polym12010099.
    10.3390/polym12010099
  2. Maria José de Jesús Valle; Paula Coutinho; Maximiano Prata Ribeiro; Amparo Sánchez Navarro. "Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation". European Journal of Pharmaceutical Sciences 122 (2018): 144-151. https://doi.org/10.1016/j.ejps.2018.06.030.
    10.1016/j.ejps.2018.06.030
  3. María De Jesús Valle; Pablo Gil González; Maximiano Prata Ribeiro; André Araujo; Amparo Sánchez Navarro. "Sildenafil Citrate Liposomes for Pulmonary Delivery by Ultrasonic Nebulization". Applied Sciences 8 8 (2018): 1291-1291. https://doi.org/10.3390/app8081291.
    10.3390/app8081291
  4. María José de Jesús Valle; Cristina Maderuelo Martín; Aránzazu Zarzuelo Castañeda; Amparo Sánchez Navarro. "Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation". European Journal of Pharmaceutical Sciences 106 (2017): 159-165. https://doi.org/10.1016/j.ejps.2017.05.066.
    10.1016/j.ejps.2017.05.066
  5. de Jesús Valle MJ; López Díaz D; Velázquez Salicio M; Sánchez Navarro A. "Development and In Vitro Evaluation of a Novel Drug Delivery System (Albumin Microspheres Containing Liposomes) Applied to Vancomycin.". (2016): http://europepmc.org/abstract/med/27290625.
    10.1016/j.xphs.2016.05.009
  6. Navarro AS. "Therapeutic drug monitoring and pharmacokinetics/pharmacodynamics of antibiotics as useful tools for translational research and personalized medicine.". (2015): http://europepmc.org/abstract/med/25940824.
    10.1007/s40262-015-0274-2
  7. Navarro, Amparo. "Liposomes Prepared in Absence of Organic Solvents: Sonication Versus". Current Pharmaceutical Analysis (2015):
  8. Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ. "Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.". (2009): http://europepmc.org/abstract/med/19492872.
    10.2165/00003088-200948040-00005
  9. Navarro AS. "Relevance of antibacterial distribution: the particular case of bone penetration.". (2009): http://europepmc.org/abstract/med/19271784.
    10.2165/00003088-200948020-00004
  10. Jesús Valle MJ; López FG; Navarro AS. "Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study.". (2008): http://europepmc.org/abstract/med/18639406.
    10.1016/j.jpba.2008.05.040
  11. de Jesús Valle MJ; Dinis-Oliveira RJ; Carvalho F; Bastos ML; Sánchez Navarro A. "Toxicological evaluation of lactose and chitosan delivered by inhalation.". (2008): http://europepmc.org/abstract/med/18325238.
    10.1163/156856208783721038
  12. Dinis-Oliveira RJ; Duarte JA; Sánchez-Navarro A; Remião F; Bastos ML; Carvalho F. "Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment.". (2008): http://europepmc.org/abstract/med/18161502.
    10.1080/10408440701669959
  13. Valle MJ; González López F; Sánchez Navarro A. "Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach for assessing pulmonary inhalation.". (2008): http://europepmc.org/abstract/med/17869149.
    10.1016/j.pupt.2007.07.003
  14. de Jesús Valle MJ; Uranga NS; López FG; Hurlé AD; Navarro AS. "Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery.". (2007): http://europepmc.org/abstract/med/17827144.
    10.1093/jac/dkm306
  15. de Jesús Valle MJ; López FG; Hurlé AD; Navarro AS. "Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung.". (2007): http://europepmc.org/abstract/med/17682107.
    10.1128/AAC.00099-07
  16. Dinis-Oliveira RJ; Sousa C; Remião F; Duarte JA; Ferreira R; Sánchez Navarro A; Bastos ML; Carvalho F. "Sodium salicylate prevents paraquat-induced apoptosis in the rat lung.". (2007): http://europepmc.org/abstract/med/17561093.
    10.1016/j.freeradbiomed.2007.03.014
  17. Dinis-Oliveira RJ; Sousa C; Remião F; Duarte JA; Navarro AS; Bastos ML; Carvalho F. "Full survival of paraquat-exposed rats after treatment with sodium salicylate.". (2007): http://europepmc.org/abstract/med/17349929.
    10.1016/j.freeradbiomed.2006.12.031
  18. del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A. "Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.". (2007): http://europepmc.org/abstract/med/17165021.
    10.1007/s00134-006-0470-5
  19. Dinis-Oliveira RJ; Remião F; Carmo H; Duarte JA; Navarro AS; Bastos ML; Carvalho F. "Paraquat exposure as an etiological factor of Parkinson's disease.". (2006): http://europepmc.org/abstract/med/16815551.
    10.1016/j.neuro.2006.05.012
  20. Dinis-Oliveira RJ; Duarte JA; Remião F; Sánchez-Navarro A; Bastos ML; Carvalho F. "Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats.". (2006): http://europepmc.org/abstract/med/16956706.
    10.1016/j.tox.2006.07.025
  21. Dinis-Oliveira RJ; De Jesús Valle MJ; Bastos ML; Carvalho F; Sánchez Navarro A. "Kinetics of paraquat in the isolated rat lung: Influence of sodium depletion.". (2006): http://europepmc.org/abstract/med/16891252.
    10.1080/00498250600790331
  22. Martínez Martínez MS; Gandarillas CI; Martínez Lanao J; Sánchez Navarro A. "Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.". (2005): http://europepmc.org/abstract/med/15969945.
    10.1211/0022357056479
  23. Santos Martínez Martínez M; Colino Gandarillas CI; Lanao JM; Sánchez Navarro A. "Influence of flow rate on the disposition of levofloxacin and netilmicin in the isolated rat lung.". (2005): http://europepmc.org/abstract/med/15734299.
    10.1016/j.ejps.2004.11.008
  24. Sánchez Navarro A; Colino Gandarillas CI; Alvarez Lerma F; Menacho YA; Domínguez-Gil A. "Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients.". (2005): http://europepmc.org/abstract/med/15910010.
    10.2165/00003088-200544060-00004
  25. Sánchez Navarro A. "New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.". (2005): http://europepmc.org/abstract/med/16231964.
    10.2165/00003088-200544110-00001
  26. Zarzuelo A; Lanao JM; López FG; Sánchez-Navarro A. "Influence of the infusion rate on disposition of netilmicin in the isolated rat perfused kidney.". (2002): http://europepmc.org/abstract/med/12128167.
    10.1016/S0928-0987(02)00079-9
  27. Sánchez Navarro MD; Sayalero Marinero ML; Sánchez Navarro A. "Pharmacokinetic/pharmacodynamic modelling of ciprofloxacin 250 mg/12 h versus 500 mg/24 h for urinary infections.". (2002): http://europepmc.org/abstract/med/12096008.
    10.1093/jac/dkf079
  28. Sánchez Navarro MD; Coloma Milano C; Zarzuelo Castañeda A; Sayalero Marinero ML; Sánchez-Navarro A. "Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients.". (2002): http://europepmc.org/abstract/med/12405867.
    10.2165/00003088-200241140-00005
  29. Zarzuelo A; Sánchez-Navarro A; López FG; Lanao JM. "Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat.". (2002): http://europepmc.org/abstract/med/12064371.
    10.1007/BF03190427